Pristyn Care

In a bid to curb the spread of the #coronavirus, the biggest #vaccination drive has been launched in India. As of now, India has granted emergency authorization to Serum Institute of India’s #Covishield and Bharat Biotech’s #Covaxin. To spread awareness about the vaccination among the people, Pristyn Care has initiated a Public Service Campaign where different queries and concerns regarding the vaccine shall be answered by Dr. Milind Joshi, General Surgeon at Pristyn Care. LIVE Q&A Session on COVID VACCINE Ask your question to Dr Milind- General Surgeon, Pristyn Care on 26 Jan Tues 6 PM. Register Now for FREE http://bit.ly/2KC8K0A#Covid, #COVID19, #Covid19Vaccine #IndiaFightsCovid19, #India, #stopthespread #coronavirus #vaccination #Covishield #Covaxin #Covid #COVID19 #Covid19Vaccine #IndiaFightsCovid19 #India #stopthespread

A 30-year-old #Delhi resident, on Friday, was given the first dose of undertrial #coronavirus vaccine #Covaxin at Delhi's All India Institute Of Medical Sciences (#AIIMS). "The first dose of 0.5 ml intramuscular injection was given to him around 1.30 pm. No immediate side-effects have been observed so far. He was under observation for two hours and will be monitored for the next seven days," Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS said. Over 2,000 volunteers have enrolled for the first phase of human clinical trial of Covaxin. #Delhi #coronavirus #Covaxin #AIIMS

A 30-year-old #Delhi resident, on Friday, was given the first dose of undertrial #coronavirus vaccine #Covaxin at Delhi's All India Institute Of Medical Sciences (#AIIMS). "The first dose of 0.5 ml intramuscular injection was given to him around 1.30 pm. No immediate side-effects have been observed so far. He was under observation for two hours and will be monitored for the next seven days," Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS said. Over 2,000 volunteers have enrolled for the first phase of human clinical trial of Covaxin. #Delhi #coronavirus #Covaxin #AIIMS

Human trials for India's first #COVID-19 vaccine, #COVAXIN, are beginning today at the All India Institute of Medical Sciences #AIIMSS). In Phase I, the vaccine would be tested on 375 volunteers; 100 of them would be from the AIIMS. AIIMS, New Delhi is among the 12 sites which have been selected by the Indian Council for Medical Research (ICMR) for conducting the Phase I and Phase II human trials for Covaxin. #COVID #COVAXIN #AIIMSS

India’s first #COVID-19 vaccine candidate #COVAXIN has received the approval of drug regulator DCGI for phase I and II of human clinical trials. The drug has been developed by Bharat Biotech. Human clinical trials are scheduled to start across India in July 2020. #COVID #COVAXIN